Camp4 Therapeutics Files Proxy Statement for 2025 Meeting
Ticker: CAMP · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1736730
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Camp4 Proxy Statement filed. Annual meeting June 11. Vote your shares!
AI Summary
Camp4 Therapeutics Corp. filed its definitive proxy statement on April 30, 2025, for its annual meeting on June 11, 2025. The filing covers the fiscal year ending December 31, 2024. The company is based in Cambridge, MA, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing provides shareholders with crucial information regarding the company's governance, executive compensation, and proposals to be voted on at the upcoming annual meeting, impacting their investment decisions.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain new material financial information or significant strategic changes.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the proxy statement.)
Key Players & Entities
- Camp4 Therapeutics Corp. (company) — Registrant
- 20250430 (date) — Filing Date
- 20250611 (date) — Meeting Date
- Cambridge, MA (location) — Company Headquarters
FAQ
What is the purpose of this DEF 14A filing?
This filing is a definitive proxy statement filed by Camp4 Therapeutics Corp. pursuant to Section 14(a) of the Securities Exchange Act of 1934, providing information for shareholders regarding the annual meeting.
When is Camp4 Therapeutics Corp.'s annual meeting scheduled?
The annual meeting is scheduled for June 11, 2025.
What is the filing date of this proxy statement?
The definitive proxy statement was filed on April 30, 2025.
Where is Camp4 Therapeutics Corp. located?
Camp4 Therapeutics Corp. is located at One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA 02139.
What is the fiscal year end for Camp4 Therapeutics Corp.?
The fiscal year end for Camp4 Therapeutics Corp. is December 31.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding Camp4 Therapeutics Corp (CAMP).